ASReview vs RevMan

ASReview is a free, open-source tool that uses AI-aided active learning to prioritize records for systematic review screening, with a human making screening decisions. Its site says the approach can reduce screening workload by up to 95%. Users can simulate AI-aided review to compare models, while Crowdscreen supports parallel screening with access managed by administrators through a private login system. The described model families are ELAS-Ultra, ELAS-Heavy, and language-agnostic ELAS-L; ELAS-Heavy and ELAS-L require the Dory package. ASReview works with reference managers including EndNote and PubMed, and imports and exports CSV, RIS, and XLSX files. Documentation includes a Python API, while the institutional workflow also describes a REST API and CLI for automation. In a local setup, data stays on the user's computer; server deployments keep it in the organization's environment and follow its policies. Support includes documentation, tutorials, videos, community discussion, and organizational workshops and consultancy. ASReview LAB costs nothing with no licensing fees or subscriptions, though running hardware or a server may incur costs.

RevMan is Cochrane’s software for building systematic reviews, from structured data entry and analysis to presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis options include pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Authors can work from ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence, and RIS reference imports can draw on Crossref, PubMed, or CRS. A free practice review is deleted after 30 days and permits one person, with no data export. Free access is also available to authors working on Cochrane Reviews. Individual annual plans are £80 a year for eligible students, £100 a year for eligible academics, and £130 a year for standard subscriptions; VAT applies in the EU and UK.